Cargando…
Proton pump inhibitors and the incidence of Clostridium difficile on the intensive care unit
Autores principales: | Whitehead, I, Smith, J, Bellamy, R, Bonner, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095202/ http://dx.doi.org/10.1186/cc5308 |
Ejemplares similares
-
P029: Regional differences in Clostridium difficile infections (CDI) in relation to fluoroquinolone (FQ) and proton pump inhibitor (PPI) use, Finland, 2008-2011
por: Kanerva, M, et al.
Publicado: (2013) -
Outbreak of severe Clostridium difficile-associated colitis with MOF in Quebec intensive care units: first analysis in Sherbrooke ICUs
por: Lamontagne, F, et al.
Publicado: (2005) -
The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
por: Tawam, Dania, et al.
Publicado: (2021) -
Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
por: Inghammar, Malin, et al.
Publicado: (2021) -
Clostridium difficile infection in ICU patients
por: Belesiotou, E, et al.
Publicado: (2014)